87 related articles for article (PubMed ID: 25136033)
21. From multidisciplinary to personalized treatment of colorectal liver metastases: 4 reasons to consider RAS.
Vauthey JN; Kopetz SE
Cancer; 2013 Dec; 119(23):4083-5. PubMed ID: 24105015
[No Abstract] [Full Text] [Related]
22. TRAP1 regulates stemness through Wnt/β-catenin pathway in human colorectal carcinoma.
Lettini G; Sisinni L; Condelli V; Matassa DS; Simeon V; Maddalena F; Gemei M; Lopes E; Vita G; Del Vecchio L; Esposito F; Landriscina M
Cell Death Differ; 2016 Nov; 23(11):1792-1803. PubMed ID: 27662365
[TBL] [Abstract][Full Text] [Related]
23. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression.
Janssen KP; Alberici P; Fsihi H; Gaspar C; Breukel C; Franken P; Rosty C; Abal M; El Marjou F; Smits R; Louvard D; Fodde R; Robine S
Gastroenterology; 2006 Oct; 131(4):1096-109. PubMed ID: 17030180
[TBL] [Abstract][Full Text] [Related]
24. KRAS mutations in primary and metastatic colorectal cancer.
Han CB; Li F; Ma JT; Zou HW
Int J Colorectal Dis; 2013 May; 28(5):731-2. PubMed ID: 22744738
[No Abstract] [Full Text] [Related]
25. Cancer: Entangled pathways.
Bernards R
Nature; 2008 Sep; 455(7212):479-80. PubMed ID: 18818647
[No Abstract] [Full Text] [Related]
26. Wnt/β Catenin-Mediated Signaling Commonly Altered in Colorectal Cancer.
Deitrick J; Pruitt WM
Prog Mol Biol Transl Sci; 2016; 144():49-68. PubMed ID: 27865466
[TBL] [Abstract][Full Text] [Related]
27. Stem cells in colon cancer.
Pohl A; Lurje G; Kahn M; Lenz HJ
Clin Colorectal Cancer; 2008 Mar; 7(2):92-8. PubMed ID: 18501067
[TBL] [Abstract][Full Text] [Related]
28. WNT5A exhibits tumor-suppressive activity through antagonizing the Wnt/beta-catenin signaling, and is frequently methylated in colorectal cancer.
Ying J; Li H; Yu J; Ng KM; Poon FF; Wong SC; Chan AT; Sung JJ; Tao Q
Clin Cancer Res; 2008 Jan; 14(1):55-61. PubMed ID: 18172252
[TBL] [Abstract][Full Text] [Related]
29. Stromal cells do not share KRAS mutations that the epithelial component harbors in colorectal carcinomas.
Baloglu H; Yigit N
Cancer Lett; 2011 Sep; 308(1):118-21. PubMed ID: 21624768
[TBL] [Abstract][Full Text] [Related]
30. SATB1 and colorectal cancer in Wnt/β-catenin signaling: Is there a functional link?
Meng WJ; Yan H; Li Y; Zhou ZG
Med Hypotheses; 2011 Feb; 76(2):277-9. PubMed ID: 21122998
[TBL] [Abstract][Full Text] [Related]
31. Oncogenic KRAS is not necessary for Wnt signalling activation in APC-associated FAP adenomas.
Obrador-Hevia A; Chin SF; González S; Rees J; Vilardell F; Greenson JK; Cordero D; Moreno V; Caldas C; Capellá G
J Pathol; 2010 May; 221(1):57-67. PubMed ID: 20196079
[TBL] [Abstract][Full Text] [Related]
32. Impact of KRAS and BRAF gene mutations on targeted therapies in colorectal cancer.
Bass A
J Clin Oncol; 2011 Jul; 29(19):2728-9. PubMed ID: 21646605
[No Abstract] [Full Text] [Related]
33. Gankyrin sustains PI3K/GSK-3β/β-catenin signal activation and promotes colorectal cancer aggressiveness and progression.
He F; Chen H; Yang P; Wu Q; Zhang T; Wang C; Wei J; Chen Z; Hu H; Li W; Cao J
Oncotarget; 2016 Dec; 7(49):81156-81171. PubMed ID: 27835604
[TBL] [Abstract][Full Text] [Related]
34. Wnt signaling in stem and cancer stem cells.
Holland JD; Klaus A; Garratt AN; Birchmeier W
Curr Opin Cell Biol; 2013 Apr; 25(2):254-64. PubMed ID: 23347562
[TBL] [Abstract][Full Text] [Related]
35. BCL9-2 promotes early stages of intestinal tumor progression.
Brembeck FH; Wiese M; Zatula N; Grigoryan T; Dai Y; Fritzmann J; Birchmeier W
Gastroenterology; 2011 Oct; 141(4):1359-70, 1370.e1-3. PubMed ID: 21703997
[TBL] [Abstract][Full Text] [Related]
36. Tubular adenomas with minor villous changes show molecular features characteristic of tubulovillous adenomas.
Ishii T; Notohara K; Umapathy A; Mallitt KA; Chikuba H; Moritani Y; Tanaka N; Rosty C; Matsubara N; Jass J; Leggett B; Whitehall V
Am J Surg Pathol; 2011 Feb; 35(2):212-20. PubMed ID: 21263241
[TBL] [Abstract][Full Text] [Related]
37. KY1022, a small molecule destabilizing Ras via targeting the Wnt/β-catenin pathway, inhibits development of metastatic colorectal cancer.
Cho YH; Cha PH; Kaduwal S; Park JC; Lee SK; Yoon JS; Shin W; Kim H; Ro EJ; Koo KH; Park KS; Han G; Choi KY
Oncotarget; 2016 Dec; 7(49):81727-81740. PubMed ID: 27835580
[TBL] [Abstract][Full Text] [Related]
38. IWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/β-catenin signaling as well as survivin expression.
Lee SC; Kim OH; Lee SK; Kim SJ
Oncotarget; 2015 Sep; 6(29):27146-59. PubMed ID: 26450645
[TBL] [Abstract][Full Text] [Related]
39. [Mutation of EGFR signaling pathway and therapy for metastatic colorectal cancer].
Nozawa K; Watanabe T
Gan To Kagaku Ryoho; 2010 May; 37(5):791-4. PubMed ID: 20495308
[TBL] [Abstract][Full Text] [Related]
40. Ras stabilization through aberrant activation of Wnt/β-catenin signaling promotes intestinal tumorigenesis.
Jeong WJ; Yoon J; Park JC; Lee SH; Lee SH; Kaduwal S; Kim H; Yoon JB; Choi KY
Sci Signal; 2012 Apr; 5(219):ra30. PubMed ID: 22494971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
